-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Allarity Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2020 to Q2 2024.
- Allarity Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 15M shares, a 80342% increase year-over-year.
- Allarity Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.99M shares, a 29154% increase from 2022.
- Allarity Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 6.81K shares, a 99.9% decline from 2021.
- Allarity Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 6.36M shares, a 94.8% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)